« Back
Home /
EBV EBNA-3A 379-387 (HLA-B*07:02)

EBV EBNA-3A 379-387 (HLA-B*07:02)

Item no.	EP05817_5
Manufacturer	peptides & elephants
Amount	5 mg
Quantity options	1 mg 5 mg
Category	Peptides & Proteins Peptides
Type	Peptides
Specific against	other
Purity	0,95
Sequence	RPPIFIRRL
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	RPPIFIRRL Epstein-Barr nuclear antigen HLA-B*07:02 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Available
Manufacturer - Applications	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Manufacturer - Category	Peptides
Shipping Temperature	freeze dried
Storage Conditions	Store dry at -20°C
C-Terminus	OH
N-Terminus	H
Counter-Ion	TFA
Description	Antigen Peptide EBV EBNA3A HLA-B07:02 (RPPIFIRRL) for stimulation of human EBV EBNA-3A (379-387) specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B0702 allele.
Gene	EBNA
Indication	Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Protein	Epstein-Barr nuclear antigen
Allele	HLA-B*07:02
Remarks	sterile and endotoxin free

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 11/6/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer